A. Paul Chous, MA, OD, FAAO, CDE
The OD’s role with new diabetes drugs
It is important for eyecare providers to be familiar with these new drugs and findings. We often see patients with diabetes, metabolic syndrome, and high CV risk, and we are in a position to help counsel our patients about new treatments—and even suggest that appropriate patients have conversations with their primary-care physicians, endocrinologists and cardiologists.
New strategies to assess the risk of diabetes-related vision loss
A colleague recently told me that eye doctors should “stay within the lines” of traditional eye care because we barely have enough time as it is to do our jobs. My response was that today more than half of our adult patients have either diabetes or prediabetes, so our job now requires we go ”outside the lines” to avoid the leading cause of preventable blindness.
How diabetes is linked to gut bacteria
Given this abundance of nonhuman species living on and within our bodies, it is not surprising that there is a link between specific bacteria to systemic and ocular disease—including diabetes and diabetes-related eye disease.
Using OCT with your diabetes patients
OCT is one of the best way to assess patients for the presence of diabetic macular edema (DME)
Fasting regimens may be key in treating type 2 diabetes
Fasting regimens have gained popularity as a technique for reducing weight and obesity. This strategy may improve insulin sensitivity in patients with insulin resistance and diabetes.
Importance of adherence and follow-up in patients with diabetic retinopathy
A 37-year-old male came to my office for the first time in 2014 for a diabetes eye examination at the insistence of his primary-care provider (PCP).
Worldwide diabetes epidemic approaches half a billion
Worldwide diabetes epidemic approaches half a billion
We had better wake up fast to address this multifactorial problem.
How a multi-component nutritional supplement benefits diabetic patients
We all know the typical algorithm for our patients having diabetes: Maintain healthy blood sugar and pressure control, get annual dilated eye examinations, and receive laser or anti-VEGF therapy if and when they develop vision-threatening diabetic retinopathy (DR).
Keeping up with the latest diabetic eye disease research
I was fortunate to attend the Association for Research in Vision and Ophthalmology (ARVO) Diabetic Retinopathy this past August.
What’s new for diabetes management and prevention
What’s new for diabetes management and prevention
From new ways of predicting who will and won’t develop diabetes, to new diabetes meds, to new evidence regarding which anti-vascular endothelial growth factor (VEGF) might be better for your specific patient, the last year has given us better tools for helping our patients with diabetes.


View Results